IASO S.A.
Annual Analysts' Briefing
Annual Analysts' Briefing
In accordance with the Athens Stock Exchange Regulation (article 292, paragraph 4, section a), IASO S.A. announces that the annual briefing of analysts took place on 13.05.2008, at the Association of Greek Institutional Investors premises. The briefing was conducted by the Group's CEO Mr. Takis Gianniris, the Group's Chief Financial Officer Mr. Vassilis Anastassakis and the Group's Investor Relations Manager Mr Konstantinos Segredakis.
The healthcare sector prospects and developments in Greece were presented as well as the position of IASO Group in the sector. Based on its Group Business Development Plan, IASO is anticipated to invest an additional amount of euro 140 mil. during the next three years, aiming at covering a broad range of health care services in strategically selected locations in Greece.
Regarding the individual companies of the group, the presentation covered the excellent financial performance of IASO SA, the significant improvement of IASO General's financial results for the FY 2007, together with the excellent prospects of the subsidiary company MedStem Services, whose main business is the processing and storage of cord blood and stem cells. The group's management pointed out that the IASO Pediatrics Department will commence operations within the 2nd half of 2008. As far as IASO Thessalias' is concerned, it is the first step towards accomplishing the Group's strategic plan for geographical expansion beyond Attica region. It will be a fully developed General and Obstetrics hospital, with Adults and Neonatal ICUs, diagnostic departments, as well as an Artificial Kidney and In Vitro Fertilization units. IASO Thessalias will commence full operations by the year 2009. Finally the development of a General and Obstetrics hospital that will cover the healthcare needs of the Attica's Southern Suburbs is amongst the midterm plans of the IASO Group.
For more information, investors may address to our corporate website: www.iaso.gr.
In accordance with the Athens Stock Exchange Regulation (article 292, paragraph 4, section a), IASO S.A. announces that the annual briefing of analysts took place on 13.05.2008, at the Association of Greek Institutional Investors premises. The briefing was conducted by the Group's CEO Mr. Takis Gianniris, the Group's Chief Financial Officer Mr. Vassilis Anastassakis and the Group's Investor Relations Manager Mr Konstantinos Segredakis.
The healthcare sector prospects and developments in Greece were presented as well as the position of IASO Group in the sector. Based on its Group Business Development Plan, IASO is anticipated to invest an additional amount of euro 140 mil. during the next three years, aiming at covering a broad range of health care services in strategically selected locations in Greece.
Regarding the individual companies of the group, the presentation covered the excellent financial performance of IASO SA, the significant improvement of IASO General's financial results for the FY 2007, together with the excellent prospects of the subsidiary company MedStem Services, whose main business is the processing and storage of cord blood and stem cells. The group's management pointed out that the IASO Pediatrics Department will commence operations within the 2nd half of 2008. As far as IASO Thessalias' is concerned, it is the first step towards accomplishing the Group's strategic plan for geographical expansion beyond Attica region. It will be a fully developed General and Obstetrics hospital, with Adults and Neonatal ICUs, diagnostic departments, as well as an Artificial Kidney and In Vitro Fertilization units. IASO Thessalias will commence full operations by the year 2009. Finally the development of a General and Obstetrics hospital that will cover the healthcare needs of the Attica's Southern Suburbs is amongst the midterm plans of the IASO Group.
For more information, investors may address to our corporate website: www.iaso.gr.